首页> 外文期刊>Cardiovascular Journal >Primary Angioplasty for the Treatment of Acute ST Elevated Myocardial Infarction: Single Centre Experience
【24h】

Primary Angioplasty for the Treatment of Acute ST Elevated Myocardial Infarction: Single Centre Experience

机译:原发性血管成形术治疗急性ST段抬高型心肌梗死:单中心经验

获取原文
           

摘要

Background: Worldwide primary angioplasty is a recommended strategy of reperfusion in patient with acute myocardial infarction as because it ensures reperfusion of the infarct-related vessels more than 90% where as, with thrombolytics it is only 60-70%. Methods: It is a retrospective observational study includes all patients treated with primary angioplasty at United Hospital from Between March 2007 to August 2010. Total 237 consecutive patients with acute myocardial infarction were treated with primary angioplasty were included. Those presented beyond 12 hours of onset of chest pain, in cardiogenic shock, resuscitate and intubated before the procedural were excluded from the study. Results: Majority (76%) of the patient were male, age was minimum 28 years and maximum 80 years, 41.5% were diabetics, 58.4% were hypertensive, 43.5 %were dyslipidaemic, 17% were smoker, 29.3% with positive family history. Fifty seven percent patients presented with anterior MI, 42 % with inferior MI and 1 % with lateral MI. Left anterior descending (LAD) is the most common vessel involved (S7%), followed by Right coronary artery (RCA) 31 %, Left circumflex artery (LCD 8 %, Ramus 1.3 % and Graft vessel 2.7%. Our door to balloon time was minimum 23 min, maximum 184 min. We used drug eluting stents for most of the patients , GP IIbIIIa receptor Mockers used in 50% cases and thrombus suction device were used when indicated. We faced complications like arrhythmias in 24% hypotension in18 %, no flow or slow flow in 45%, cardiac arrest in 3% and coronary perforation in 1. %. Our overall survival was 97.9 %. Conclusion: Primary angioplasty is a emerging area in the context 149-154 of our country . Many of the new centers start this novel strategy which helps to save many lives. Primary angioplasty is feasible and safe method of reperfusion in patient with acute myocardial infarction in our center.
机译:背景:急性心肌梗死患者建议采用全球一次血管成形术再灌注策略,因为它可确保梗死相关血管的再灌注超过90%,而溶栓剂仅为60-70%。方法:这是一项回顾性观察性研究,纳入了2007年3月至2010年8月间在联合医院接受原发性血管成形术治疗的所有患者。包括237例连续的急性心肌梗死患者接受了原发性血管成形术治疗。那些在手术前12小时以上出现胸痛,心源性休克,复苏和插管的患者被排除在研究之外。结果:多数患者(76%)为男性,年龄在最小28岁至最大80岁之间,糖尿病患者41.5%,高血压患者58.4%,血脂异常患者43.5%,吸烟者17%,家族史阳性的29.3%。 57%的患者表现为前部MI,42%的患者为下MI和1%的患者为MI。左前降支(LAD)是最常见的血管(S7%),其次是右冠状动脉(RCA)31%,左回旋支动脉(LCD 8%,Ramus 1.3%和Graft血管2.7%)。最少需要23分钟,最多需要184分钟。我们对大多数患者使用药物洗脱支架,在50%的病例中使用GP IIbIIIa受体Mockers,并在需要时使用血栓抽吸装置,在24%的低血压患者中面临18%的心律不齐,无血流或缓慢血流的比例为45%,心脏骤停的比例为3%,冠状动脉穿孔的比例为1.%,我们的总生存率为97.9%。结论:在我国149-154年,初级血管成形术是一个新兴领域。新的中心开始采用这种新颖的策略来挽救许多生命,我们的中心对急性心肌梗死的患者进行原位血管成形术是可行且安全的再灌注方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号